SEARCH

SEARCH BY CITATION

References

  • 1
    Frizzera G, Moran EM, Rappaport H. Angioimmunoblastic lymphadenopathy with dysproteinemia. Lancet 1974; 1: 10701073.
  • 2
    Lukes RJ, Tindle BH. Immunoblastic lymphadenopathy: A hyperimmune entity resembling Hodgkin's disease. N Engl J Med 1975; 292: 18.
  • 3
    Frizzera G, Moran EM, Rappaport H. Angioimmunoblastic lymphadenopathy: Diagnosis and clinical course. Am J Med 1975; 59: 803818.
  • 4
    Feremans WW, Khodadadi E. Alpha-interferon therapy in refractory angioimmunoblastic lymphadenopathy. Eur J Haeniatol 1987; 37: 91.
  • 5
    Rossi JF, Fegueux N, Calvet B, Godefroy W. Alpha-interferon in angioimmunoblastic lymphadenopathy. Ann Intern Med 1988; 15: 512513.
  • 6
    Lawrence MW, Strickler JG, Dorfman RF, Hornig SJ, Warnke RA, Sklar J. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pafhol 1986; 122: 392397.
  • 7
    Knecht H, Odermatt BF, Hayoz D, Kuhn L, Bachmann F. Polyclonal rearrangements of the T-cell receptor P-chain in fatal angioimmunoblastic lymphadenopathy. Br J Haematol 1989; 73: 491496.
  • 8
    Honda M, Smith HR, Steinberg AD. Studies of the pathogenesis of angioimmunoblastic lymphadenopathy. J Clin Invest 1985; 76: 332340.
  • 9
    Borel JF. Mechanism of action and rationale for cyclosporin A in psoriasis. Br J Dermatol 1990; 122512.
  • 10
    Steinberg AD, Seldin MF, Jaffe ES et al. Angioimmunoblastic lymphadenopathy with dysproteinemia. Ann Intern Med 1988; 108: 575584.
  • 11
    Banavali SD, Parikh PM, Charak BS et al Danazol in treatment of angioimmunoblastic lymphadenopathy. Cancer 1989; 64: 613615.